Reagenzien und Instrumente für die Immunologie Zellbiologie und Molekularbiologie
Clinisciences > > QR-6401 is a CDK2 inhibitor. QR-6401 demonstrated robust antitumor efficacy in an OVCAR3 ovarian cancer xenograft model via oral administration.
QR-6401 is a CDK2 inhibitor. QR-6401 demonstrated robust antitumor efficacy in an OVCAR3 ovarian cancer xenograft model via oral administration.
